Education
About Us
Working with TipRanks
Follow Us
Amarin Corporation Plc (AMRN)
NASDAQ:AMRN
AMRN Stock Chart & Stats
$14.78
-$0.01(-2.55%)
At close: 4:00 PM EST
$14.78
-$0.01(-2.55%)
Day’s Range― - ―
52-Week Range$7.08 - $20.90
Previous CloseN/A
Volume726.09K
Average Volume (3M)94.36K
Market Cap
$307.40M
Enterprise Value$44.47M
Total Cash (Recent Filing)$286.59M
Total Debt (Recent Filing)$6.73M
Price to Earnings (P/E)―
Beta1.47
Next Earnings
Mar 03, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding20,792,685
10 Day Avg. Volume104,305
30 Day Avg. Volume94,361
Financial Highlights & Ratios
PEG Ratio-1.46
Price to Book (P/B)8.20
Price to Sales (P/S)17.44
P/FCF Ratio-128.50
Enterprise Value/Market Cap0.14
Enterprise Value/Revenue0.20
Enterprise Value/Gross Profit0.50
Enterprise Value/Ebitda-0.85
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.14
Revenue Forecast (FY)$200.99M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthThe total revenues included a $25M upfront payment from the Recordati deal, contributing to the overall revenue growth.
Strategic PartnershipsThe Recordati partnership in Europe helps reshape Amarin's business model by transferring commercialization to a seasoned local partner with established cardiovascular infrastructure and expertise.
Bears Say
Competition ChallengesThe longer-term outlook for the US Vascepa business remains conservative given growing pressure from generic competitors.
Market CompetitionInvestors may remain cautious about the commercial business as the US VASCEPA franchise continues to face significant pressure from at least eight generic competitors.
Amarin News
AMRN FAQ
What was Amarin Corporation Plc’s price range in the past 12 months?
Amarin Corporation Plc lowest stock price was $7.08 and its highest was $20.90 in the past 12 months.
What is Amarin Corporation Plc’s market cap?
Amarin Corporation Plc’s market cap is $307.40M.
When is Amarin Corporation Plc’s upcoming earnings report date?
Amarin Corporation Plc’s upcoming earnings report date is Mar 03, 2026 which is in 43 days.
How were Amarin Corporation Plc’s earnings last quarter?
Amarin Corporation Plc released its earnings results on Oct 29, 2025. The company reported -$0.02 earnings per share for the quarter, beating the consensus estimate of -$0.43 by $0.41.
Is Amarin Corporation Plc overvalued?
According to Wall Street analysts Amarin Corporation Plc’s price is currently Overvalued.
Does Amarin Corporation Plc pay dividends?
Amarin Corporation Plc does not currently pay dividends.
What is Amarin Corporation Plc’s EPS estimate?
Amarin Corporation Plc’s EPS estimate is 0.03.
How many shares outstanding does Amarin Corporation Plc have?
Amarin Corporation Plc has 20,792,685 shares outstanding.
What happened to Amarin Corporation Plc’s price movement after its last earnings report?
Amarin Corporation Plc reported an EPS of -$0.02 in its last earnings report, beating expectations of -$0.43. Following the earnings report the stock price went down -11.246%.
Which hedge fund is a major shareholder of Amarin Corporation Plc?
Currently, no hedge funds are holding shares in AMRN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Amarin Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
AMRN Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 11.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 9.9%
Last 30 Days ▲ 13.9%
Last 30 Days ▲ 13.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
33.39%
12-Months-Change
Fundamentals
Return on Equity
-17.35%
Trailing 12-Months
Asset Growth
-12.10%
Trailing 12-Months
Company Description
Amarin Corporation Plc
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
AMRN Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a positive outlook due to significant growth in U.S. market sales, successful partnerships, and strategic cost reductions. However, challenges remain with declining Rest of World revenue and ongoing restructuring costs.View all AMRN earnings summariesTechnical Analysis
Altimmune
―
Rigel
―
Aldeyra Therapeutics
―
Rocket Pharmaceuticals
―
Corvus Pharmaceuticals
―
Ownership Overview
0.69% Insiders
1.78% Mutual Funds
11.58% Other Institutional Investors
85.84% Public Companies and
Individual Investors